SCHEMBL103238

SCHEMBL103238

CCCc1cc(C(=O)Oc2c(F)c(F)c(F)c(F)c2F)ncc1N1CCN(C(=O)O)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.38
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
MAPT P10636 8/20 0.33
ALDH1A1 P00352 6/20 0.33
TSHR P16473 3/20 0.33
HSD17B10 Q99714 3/20 0.33
HPGD P15428 2/20 0.33
ALOX15 P16050 2/20 0.33
KDM4E B2RXH2 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
LMNA P02545 4/20 0.32
MAPK1 P28482 2/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
TRPC6 Q9Y210 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL104475 0.88 GPR119 (0.42) HTTMEN1KMT2AMAPTTSHR
SCHEMBL3601001 0.73 IDO1 (0.37) HTTMEN1KMT2AMAPTALDH1A1
SCHEMBL103379 0.73 CKS1B (0.47) MEN1KMT2AMAPTTSHRSMN1; SMN2
SCHEMBL3593569 0.68 RORC (0.37) KMT2AMAPTALDH1A1HSD17B10POLB
SCHEMBL5889663 0.65 TDP1 (0.41) MEN1KMT2AMAPTALDH1A1HSD17B10
SCHEMBL3595521 0.64 GPR119 (0.42) HTTMEN1KMT2A
SCHEMBL106060 0.64 L3MBTL1 (0.37) HTTMEN1KMT2AMAPTALDH1A1
SCHEMBL5889664 0.63 KDM4E (0.41) MEN1KMT2AMAPTALDH1A1TSHR
SCHEMBL4137101 0.61 L3MBTL1 (0.54) HTTMEN1KMT2AMAPTALDH1A1
SCHEMBL8414880 0.60 EGLN1 (0.41) MEN1KMT2AMAPTALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426113-B1 CARBINOL COMPOUND HAVING HETEROCYCLIC LINKER KOWA CO (JP) 2013-11-06 EP disclosed
US-8551985-B2 Carbinol derivatives having heterocyclic linker KOWA COMPANY, LTD. (JP) 2013-10-08 US disclosed
EP-2426113-A1 CARBINOL COMPOUND HAVING HETEROCYCLIC LINKER Kowa Company, Ltd. (JP) 2012-03-07 EP disclosed
US-20100280013-A1 CARBINOL DERIVATIVES HAVING HETEROCYCLIC LINKER KOWA COMPANY, LTD. (JP) 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280013-A1 CARBINOL DERIVATIVES HAVING HETEROCYCLIC LINKER NR1H2, NR1H3, CCR2 HTT 2209/4885MEN1 3479/4885KMT2A 2327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.